Soluble urokinase plasminogen activator receptor in one-year prediction of major adverse cardiac events in patients after first myocardial infarction treated with primary percutaneous coronary intervention

INTRODUCTION: Soluble urokinase plasminogen activator receptor (suPAR) level reflects the general condition of the organism and was proved to give independent information in risk stratification of patients. The aim of this study was to assess the usefulness of suPAR in the prediction of adverse card...

Descripción completa

Detalles Bibliográficos
Autores principales: Wlazeł, Rafał N., Migała, Marta, Zielińska, Marzenna, Pawlicki, Lucjan, Rośniak-Bąk, Kinga, Szadkowska, Iwona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348361/
https://www.ncbi.nlm.nih.gov/pubmed/30697255
http://dx.doi.org/10.5114/aoms.2016.63596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348361/
https://www.ncbi.nlm.nih.gov/pubmed/30697255
http://dx.doi.org/10.5114/aoms.2016.63596

Ejemplares similares